Singapore - English - HSA (Health Sciences Authority)

leica microsystems (sea) pte ltd - immunology - ncl-l-calcitonin is intended for the qualitative identification by light microscopy of calcitonin molecules in paraffin sections.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - calcitonin 0.5 mg/ml - solution for injection - 0.5 mg/ml - active: calcitonin 0.5 mg/ml

Singapore - English - HSA (Health Sciences Authority)

leica microsystems (sea) pte ltd - immunology - calcitonin (polyclonal) antibody is intended to be used for the qualitative identification by light microscopy of human calcitonin in formalin-fixed, paraffin-embedded tissue by immunohistochemical staining using the automated bond system. calcitonin (polyclonal) is recommended to identify calcitonin-expressing cells, and, as part of a panel, as an aid to differential diagnosis of thyroid malignancies. calcitonin (polyclonal) is recommended for use on tissue specimens from patients with suspected thyroid malignancies, as an adjunct to conventional histopathology using non-immunologic histochemical stains. calcitonin (polyclonal) is optimized for use on the leica biosystems automated bond-max, bond-iii or bond-prime systems using the bond polymer refine detection kit (ds9800) or bond-prime polymer dab detection system (ds9284).

Singapore - English - HSA (Health Sciences Authority)

zuellig pharma pte. ltd. - salmon calcitonin synthetic - spray - 200 iu/dose - salmon calcitonin synthetic 200 iu/dose

Singapore - English - HSA (Health Sciences Authority)

siemens healthcare pte. ltd. - immunology - the advia centaur® brahms procalcitonin (pct) assay is for in vitro diagnostic use in the quantitative determination of pct in human serum and plasma (edta, lithium heparin and sodium heparin)using the advia centaur xp, advia centaur xpt and advia centaur cp systems.it is intended for use,in conjunction with other laboratory findings and clinical assessments,as an aid in: •the risk assessment of critically ill patients on their first day of icu admission for progression to severe sepsis and septic shock. •assessing the cumulative 28 day risk of all-cause mortality for patients diagnosed with severe sepsis or septic shock in the icu or when obtained in the emergency department or other medical wards prior to icu admission, using percent change in pct level over time. •decision-making on antibiotic therapy for patients with suspected or confirmed lower respiratory tract infections. •decision-making on antibiotic discontinuation for patients with suspected or confirmed sepsis.

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - calcitonin, salmon - solution for inj/inf - 100 iu/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - calcitonin, salmon - solution for inj/inf - 50 iu/ml

United States - English - NLM (National Library of Medicine)

viatrexx bio incorporated - bone (8x, 200k), calcitonin (8x, 200k), cartilage (6x, 200k), erythrocytes (8x, 200k), interleukin 3 (8x, 200k), parathyroid (6x, 200k), vitamin d (3x, 30k) - to help support bone health and density

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

stanningley pharma ltd - calcium acetate - oral tablet - 475mg